Moleculin Biotech, Inc. Operating Lease, Payments
Moleculin Biotech, Inc. (MBRX) reported Operating Lease, Payments of $41.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-13
- Moleculin Biotech, Inc. operating lease, payments for the quarter ending 2026-06-30 was $41.00K, a 5.13% increase year-over-year.
- Moleculin Biotech, Inc. operating lease, payments for the quarter ending 2026-03-31 was $41.00K, a 5.13% increase year-over-year.
- Moleculin Biotech, Inc. operating lease, payments for the quarter ending 2025-12-31 was $41.00K, a 5.13% increase year-over-year.
- Moleculin Biotech, Inc. operating lease, payments for the quarter ending 2025-09-30 was $40.00K, a 2.56% increase year-over-year.
- Moleculin Biotech, Inc. operating lease, payments for fiscal 2025 was $160.00K, a 9.59% increase from fiscal 2024.
- Moleculin Biotech, Inc. operating lease, payments for fiscal 2024 was $146.00K, a 8.96% increase from fiscal 2023.
- Moleculin Biotech, Inc. operating lease, payments for fiscal 2023 was $134.00K, a 3.88% increase from fiscal 2022.
- Moleculin Biotech, Inc. operating lease, payments for fiscal 2022 was $129.00K, a 6.52% decline from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $41.00K 10-Q · filed 2026-08-13 | $81.00K 10-Q · filed 2026-08-13 | $123.00K derived: sum of 3 quarters · filed 2026-08-13 | $163.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $41.00K 10-Q · filed 2026-05-14 | $82.00K derived: sum of 2 quarters · filed 2026-05-14 | $122.00K derived: sum of 3 quarters · filed 2026-05-14 | $161.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $81.00K derived: sum of 2 quarters · filed 2026-03-18 | $120.00K derived: sum of 3 quarters · filed 2026-08-13 | $160.00K 10-K · filed 2026-03-18 |
| 2025-09-30 | $40.00K 10-Q · filed 2025-11-13 | $79.00K derived: sum of 2 quarters · filed 2026-08-13 | $119.00K 10-Q · filed 2025-11-13 | $157.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $39.00K 10-Q · filed 2026-08-13 | $79.00K 10-Q · filed 2026-08-13 | $117.00K derived: sum of 3 quarters · filed 2026-08-13 | $156.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $39.00K 10-Q · filed 2026-05-14 | $78.00K derived: sum of 2 quarters · filed 2026-05-14 | $117.00K derived: sum of 3 quarters · filed 2026-05-14 | $155.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $78.00K derived: sum of 2 quarters · filed 2026-03-18 | $116.00K derived: sum of 3 quarters · filed 2026-03-18 | $146.00K 10-K · filed 2026-03-18 |
| 2024-09-30 | $39.00K 10-Q · filed 2025-11-13 | $77.00K derived: sum of 2 quarters · filed 2025-11-13 | $107.00K 10-Q · filed 2025-11-13 | $131.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $38.00K 10-Q · filed 2025-08-12 | $68.00K 10-Q · filed 2025-08-12 | $92.00K derived: sum of 3 quarters · filed 2025-08-12 | $126.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $29.00K 10-Q · filed 2025-05-13 | $54.00K derived: sum of 2 quarters · filed 2025-05-13 | $88.00K derived: sum of 3 quarters · filed 2025-05-13 | $126.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $59.00K derived: sum of 2 quarters · filed 2025-03-21 | $97.00K derived: sum of 3 quarters · filed 2025-03-21 | $134.00K 10-K · filed 2025-03-21 |
| 2023-09-30 | $34.00K 10-Q · filed 2024-11-08 | $72.00K derived: sum of 2 quarters · filed 2024-11-08 | $109.00K 10-Q · filed 2024-11-08 | $148.00K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $38.00K 10-Q · filed 2024-08-13 | $75.00K 10-Q · filed 2024-08-13 | $114.00K derived: sum of 3 quarters · filed 2024-08-13 | $135.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $38.00K 10-Q · filed 2024-05-10 | $76.00K derived: sum of 2 quarters · filed 2024-05-10 | $97.00K derived: sum of 3 quarters · filed 2024-05-10 | $132.00K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $59.00K derived: sum of 2 quarters · filed 2024-03-22 | $94.00K derived: sum of 3 quarters · filed 2024-03-22 | $129.00K 10-K · filed 2024-03-22 |
| 2022-09-30 | $21.00K 10-Q · filed 2023-11-13 | $56.00K derived: sum of 2 quarters · filed 2023-11-13 | $91.00K 10-Q · filed 2023-11-13 | $126.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $35.00K 10-Q · filed 2023-08-10 | $70.00K 10-Q · filed 2023-08-10 | $105.00K derived: sum of 3 quarters · filed 2023-08-10 | $140.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $35.00K 10-Q · filed 2023-05-10 | $70.00K derived: sum of 2 quarters · filed 2023-05-10 | $105.00K derived: sum of 3 quarters · filed 2023-05-10 | $139.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $70.00K derived: sum of 2 quarters · filed 2023-03-22 | $104.00K derived: sum of 3 quarters · filed 2023-03-22 | $138.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | $35.00K 10-Q · filed 2022-11-10 | $69.00K derived: sum of 2 quarters · filed 2022-11-10 | $103.00K 10-Q · filed 2022-11-10 | $137.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $34.00K 10-Q · filed 2022-08-12 | $68.00K 10-Q · filed 2022-08-12 | $102.00K derived: sum of 3 quarters · filed 2022-08-12 | $136.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $34.00K 10-Q · filed 2022-05-11 | $68.00K derived: sum of 2 quarters · filed 2022-05-11 | $102.00K derived: sum of 3 quarters · filed 2022-05-11 | $135.00K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $68.00K derived: sum of 2 quarters · filed 2022-03-24 | $101.00K derived: sum of 3 quarters · filed 2022-03-24 | $134.00K 10-K · filed 2022-03-24 |
| 2020-09-30 | $34.00K 10-Q · filed 2021-11-10 | $67.00K derived: sum of 2 quarters · filed 2021-11-10 | $100.00K 10-Q · filed 2021-11-10 | $133.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $33.00K 10-Q · filed 2021-08-11 | $66.00K 10-Q · filed 2021-08-11 | $99.00K derived: sum of 3 quarters · filed 2021-08-11 | $119.00K derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $33.00K 10-Q · filed 2021-05-12 | $66.00K derived: sum of 2 quarters · filed 2021-05-12 | $86.00K derived: sum of 3 quarters · filed 2021-05-12 | $99.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $53.00K derived: sum of 2 quarters · filed 2021-03-24 | $66.00K derived: sum of 3 quarters · filed 2021-03-24 | $74.00K 10-K · filed 2021-03-24 |
| 2019-09-30 | $20.00K 10-Q · filed 2020-11-12 | $33.00K derived: sum of 2 quarters · filed 2020-11-12 | $41.00K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $13.00K 10-Q · filed 2020-08-12 | $21.00K 10-Q · filed 2020-08-12 | ||
| 2019-03-31 | $8.00K 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |